Evidence for immune activation against oxidized lipoproteins in inactive phases of juvenile chronic arthritis

Citation
G. Simonini et al., Evidence for immune activation against oxidized lipoproteins in inactive phases of juvenile chronic arthritis, J RHEUMATOL, 28(1), 2001, pp. 198-203
Citations number
43
Categorie Soggetti
Rheumatology,"da verificare
Journal title
JOURNAL OF RHEUMATOLOGY
ISSN journal
0315162X → ACNP
Volume
28
Issue
1
Year of publication
2001
Pages
198 - 203
Database
ISI
SICI code
0315-162X(200101)28:1<198:EFIAAO>2.0.ZU;2-3
Abstract
Objective, Oxidative stress contributes to joint inflammation and damage in rheumatoid arthritis. In a mobile inflamed joint, exercise induced multipl e cycles of hypoxia-reperfusion injury may lead to the creation of a redox environment in which oxido-reductase systems, by NADPH mechanisms, produce highly reactive chemical species (i.e., oxygen free radicals). We investiga ted 2 endproducts of lipid peroxidation, malonildialdehyde (MDA) and diene conjugates (DC), and the formation of antibodies against oxidized low densi ty lipoproteins (Ab oxLDL) in juvenile chronic arthritis (JCA), and assesse d the role of oxidative phenomena in different phases and subsets of this d isease. Methods, To assess the role of oxidative stress in JCA, we measured the end products of lipid peroxidation. MDA and DC: by the increase of absorbance a t 586 nm and 234 nm, respectively, and the levels of Ab oxLDL by ELISA in t he sera of 58 patients with JCA and 21 healthy controls. Due to crossreacti vity between Ab oxLDL and anticardiolipin antibodies (aCL), the sera were a lso tested by a standard ELISA for IgG-aCL. The patients were divided into 3 subsets: 29 with pauciarticular (pauci), 15 with polyarticular (poly), an d 14 with systemic (sys) onset disease, and then were subdivided, according to different variables appropriate to each subset, reflecting active and i nactive disease, into 30 active (14 pauci, 8 poly, 8 sys) and 28 inactive(1 5 pauci, 7 poly, 6 sys). Results. Levels of Ab oxLDL were significantly increased in the whole group of patients (566.6 +/- 263.0 vs 206.6 +/- 136.3 mU/ml; p < 0.001) and in e ach of the type of onset (pauci 660.8 <plus/minus> 272.1, p < 0.001; poly 3 41.3 <plus/minus> 134.7, p < 0.01; sys 497.8 <plus/minus> 114.8, p < 0.001) compared to controls. Ab oxLDL were higher in the inactive than in the act ive group (743.5 <plus/minus> 231.9 and 404.4 +/- 169.9; p < 0.001). MDA an d DC levels were not increased significantly in patients' sera. No patient was positive for IgG-aCL. Conclusion. These findings suggest that MDA and DC cannot be considered maj or markers of oxidative stress in JCA and that the Ab oxLDL may represent a delayed sign of oxidative stress previously induced by the inflammatory pr ocess in patients with JCA.